Search Within

Yanming Zhang

  1. "Survivorship Research"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (14)
  3. Research Letter (2)
Groups
  1. Department of Pathology and Laboratory Medicine (35)
  2. Survivorship Research (35)
  3. Center for Hematologic Malignancies (34)
  4. Department of Medicine (34)
  5. Hematologic Malignancies, Division of (32)
  6. Hematologic Malignancies Research (25)

More Groups

People
  1. Alexander Lesokhin (21)
  2. Heather Landau (19)
  3. Kylee Maclachlan (19)
  4. Malin Hultcrantz (18)
  5. Neha Korde (18)
  6. Ahmet Dogan (16)

More People

Years
  1. 2024 (5)
  2. 2023 (11)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Blood (14)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Blood Advances (3)
  4. American Journal of Hematology (2)
  5. Blood Cancer Journal (2)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Elsevier Inc. (5)
  3. Nature Publishing Group (3)
  4. John Wiley & Sons, Inc. (2)
  5. American Association for Cancer Research (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow based flow cytometry for tracking measurable residual disease (MRD) in patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E. H.; Roshal, M.; Zhang, Y.; Ciardiello, A. K.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comprehensive detection of recurring genomic abnormalities: A targeted sequencing approach for multiple myeloma
    Journal Article

    Yellapantula, V.; Hultcrantz, M.; Rustad, E. H.; Wasserman, E.; Londono, D.; Cimera, R.; Ciardiello, A.; Landau, H.; Akhlaghi, T.; Mailankody, S.; more...
    Blood Cancer Journal (2019)

    Fulltext@MSK | Save
  • Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
    Journal Article

    Diolaiti, D.; Dela Cruz, F. S.; Gundem, G.; Bouvier, N.; Boulad, M.; Zhang, Y.; Chou, A. J.; Dunkel, I. J.; Sanghvi, R.; Shah, M.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save